Top Markets
Coin of the day
Kobayashi Pharmaceutical Co., Ltd. Kobayashi Pharmaceutical Co., Ltd.

Kobayashi Pharmaceutical Co., Ltd.

4967
Clasificación en acciones #5380
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries,... Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Precio por acción
$37.07
Capitalización bursátil
$2.76B
Cambio (1 día)
-0.16%
Cambio (1 año)
1.12%
País
JP
Comercio Kobayashi Pharmaceutical Co., Ltd. (4967)
Ganancias de Kobayashi Pharmaceutical Co., Ltd. (4967)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Kobayashi Pharmaceutical Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Kobayashi Pharmaceutical Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$20.38B -
US
$9.83B -
FR
$2.94B -
US
$1.55B -
IN
$517.00M -
US